288,670 Shares in Envista Holdings Corporation $NVST Acquired by Ieq Capital LLC

Ieq Capital LLC bought a new position in Envista Holdings Corporation (NYSE:NVST) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 288,670 shares of the company’s stock, valued at approximately $7,606,000. Ieq Capital LLC owned 0.18% of Envista at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of NVST. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Envista during the second quarter valued at about $25,000. Caitong International Asset Management Co. Ltd lifted its holdings in Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after acquiring an additional 1,504 shares during the last quarter. Allworth Financial LP boosted its position in shares of Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after purchasing an additional 776 shares in the last quarter. UMB Bank n.a. boosted its position in shares of Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after purchasing an additional 636 shares in the last quarter. Finally, IFP Advisors Inc boosted its position in shares of Envista by 102.9% during the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after purchasing an additional 1,071 shares in the last quarter.

Envista Trading Up 0.0%

Shares of NYSE:NVST opened at $27.21 on Monday. The firm has a fifty day moving average of $26.90 and a two-hundred day moving average of $26.30. The firm has a market capitalization of $4.37 billion, a P/E ratio of 46.91, a price-to-earnings-growth ratio of 1.30 and a beta of 0.86. Envista Holdings Corporation has a 12-month low of $18.77 and a 12-month high of $30.42. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The business had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. During the same period in the previous year, the company posted $0.26 EPS. Envista’s revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, equities analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on NVST shares. Robert W. Baird set a $34.00 target price on shares of Envista in a research note on Thursday, August 6th. JPMorgan Chase & Co. lifted their price target on shares of Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. BMO Capital Markets started coverage on Envista in a report on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 price target on the stock. Morgan Stanley set a $23.00 price target on Envista in a report on Thursday, August 6th. Finally, Evercore reissued an “outperform” rating and set a $33.00 price objective on shares of Envista in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, Envista has an average rating of “Moderate Buy” and an average price target of $29.31.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.